...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Acute efficacy and clinical outcomes using HotBalloon for pulmonary vein isolation in patients with a left common pulmonary vein
【24h】

Acute efficacy and clinical outcomes using HotBalloon for pulmonary vein isolation in patients with a left common pulmonary vein

机译:患有左常见肺静脉患者肺静脉分离的急性疗效和临床结果

获取原文
获取原文并翻译 | 示例

摘要

Abstract Introduction HotBalloon material is compliant and the balloon size can be enlarged by increasing the intraballoon injection volume. HotBalloon‐based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal atrial fibrillation (PAF), however, the acute efficacy and clinical outcomes of the HotBalloon‐based PVI have never been fully investigated in patients with a left common pulmonary vein (LCPV). Methods and Results One hundred fifty‐three PAF patients underwent HotBalloon‐based PVI. Three‐dimensional computed tomography was performed in all patients before the ablation. An LCPV was observed in 40 (26%) patients. For HotBalloon ablation of an LCPV, in patients with an LCPV of superoinferior diameter 34?mm, the left common ostium was preferably isolated if sufficient occlusion could be achieved. In patients with an LCPV diameter ≥34?mm, left superior and inferior branches of the LCPV were targeted individually. The number of HotBalloon applications in patients with LCPV was significantly smaller than without LCPV (7.3?±?2.0 vs 8.1?±?2.1; P ?=?.04). In patients with LCPV diameter 34?mm, 75% of LCPVs successfully achieved full balloon occlusion (50% were isolated by application at the LCPV ostium alone, 25% by application at the LCPV ostium followed by either superior or inferior LCPV branch ablation) and 25% were isolated individually. One year after a single session, the arrhythmia‐free rates were similar between patients with and without LCPV (77% vs 74%, log rank, P ?=?.86). Conclusions HotBalloon‐based PVI delivers long‐term favorable success rates with fewer HotBalloon applications in paroxysmal AF patients with an LCPV.
机译:摘要介绍热滚球材料符合符合性,通过增加胃中的注射量可以扩大气球尺寸。基于热球播的肺静脉分离(PVI)已经证明令人鼓舞的临床导致治疗阵发性心房颤动(PAF),然而,从未在患有左侧常见的患者中完全研究了基于热球的PVI的急性疗效和临床结果肺静脉(LCPV)。方法和结果一百五十三个PAF患者接受了热球播的PVI。在消融之前的所有患者中进行了三维计算断层扫描。在40例(26%)患者中观察到LCPV。对于LCPV的热母球消融,在具有过流直径的LCPV的患者中,优选分离出足够的闭塞,左常见的Ostium。在患有LCPV直径≥34Ω·mm的患者中,LCPV的左上方和下分枝单独靶向。 LCPV患者的热球囊应用的数量明显小于没有LCPV(7.3?±2. 2.0 Vs 8.1?±2.1; P?= 04)。在LCPV直径的患者中,34毫米的患者,75%的LCPVs成功实现了全球闭塞(通过单独的LCPV Ostium施用,50%分离,25%通过在LCPV Ostium施用,然后是优异的或较差的LCPV分支消融)和25%单独分离。单一课程后一年,患有患者和不含LCPV的心律失常率相似(77%VS 74%,日志等级,P?= 86)。结论基于热球播的PVI可提供长期有利的成功率,在阵发性AF患者中具有较少的热球囊应用,具有LCPV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号